Titelia

Holdings of Lion Point Capital, LP

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
27 in 2 countries
Top ten
59.6 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Praxis Precision Medicines Inc 4,4501.4M $
2Geron Corp 578,000861.2K $
3Syndax Pharmaceuticals Inc 36,000841K $
4Ardelyx Inc 128,650770.6K $
5Benitec Biopharma Inc 62,000660.3K $
6Sarepta Therapeutics Inc 28,500620.2K $
7Disc Medicine Inc 8,100517.9K $
8CUE BIOPHARMA INC 2,202,854506.4K $
9Compass Pathways plc 80,000442.4K $
10Lantheus Holdings Inc 5,500417.2K $
11JASPER THERAPEUTICS INC 465,000407.4K $
12Humacyte Inc 650,000394.4K $
13Viatris Inc 27,700374.2K $
14Kura Oncology Inc 46,000374K $
15Bridgebio Pharma Inc 5,000371.3K $
16Dyne Therapeutics Inc 18,000326.3K $
17Rocket Pharmaceuticals Inc 86,000307.9K $
18Pacira BioSciences Inc 13,500305.1K $
19Edgewise Therapeutics Inc 9,100286.7K $
20Mineralys Therapeutics Inc 10,500284.4K $
21Seres Therapeutics Inc 31,570280K $
22Janux Therapeutics Inc 19,000264.1K $
23REGENXBIO Inc 26,600222.9K $
24Azenta Inc 9,700205K $
25Innoviva Inc 8,200191.1K $
26Arcutis Biotherapeutics Inc 5,250123.7K $
27SPRUCE BIOSCIENCES INC 1,00065.4K $

Download this table: CSV, JSON

Sector breakdown

  • Health care 3.2 %
  • Unattributed 96.8 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 96.3 %
  • United Kingdom 3.7 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States2611.4M $96.27 %
2United Kingdom1442.4K $3.73 %
Cite this page

Titelia. "Holdings of Lion Point Capital, LP". https://titelia.com/en/funds/US13F1643354